AUG 19, 2026 · PHASE 3 TRIAL
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
ClinicalTrials.gov
This is a Phase 3 clinical trial currently recruiting with no results posted; it describes a planned study design and endpoints, not evidence of efficacy or safety.
Reported
Planned sample size540
Primary outcome measure6-Minute Walk Distance (6MWD) change at 26…
PhasePHASE 3